Prosecution Insights
Last updated: October 01, 2026

Examiner: MEYERS, ELIZABETH ANNE

Tech Center 1600 • Art Units: 1611 1617 1629

This examiner grants 24% of resolved cases

Analysis

Elizabeth Anne Meyers, in Tech Center 1600 and Art Unit 1611, has 17 resolved cases. The allowance rate is 23.5 percent, but the interview lift is a very high 92.9 percent. This 92.9 percent lift is extremely significant compared to the 23.5 percent baseline. The 23.5 percent allowance rate is low, but the 92.9 percent lift suggests that interviews are the most effective way to get a case allowed.

The median days to allowance is 1128. While the 23.5 percent allowance rate is challenging, the 92.9 percent interview lift is a powerful tool for applicants. Counsel should be prepared for a 1128 day timeline and should always request an interview. With only 17 resolved cases, the data is limited but clear on the value of interviews. The 1128 day pendency and 92.9 percent lift are the defining characteristics of prosecution with this examiner. Utilizing the 92.9 percent lift is essential for success.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

23.5%
Allow Rate
-36.5% vs TC avg
79
Total Applications
+92.9%
Interview Lift
1128
Avg Prosecution Days
Based on 17 resolved cases, 2023–2026

Rejection Statute Breakdown

0.9%
§101 Eligibility
9.0%
§102 Novelty
44.1%
§103 Obviousness
25.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18743381 DEODORANT COMPOSITIONS COMPRISING CARBOXYLIC ACIDS Final Rejection The Procter & Gamble Company
18318805 HAIR CONDITIONER COMPOSITIONS CONTAINING NON-SILICONE CONDITIONING AGENTS Non-Final OA The Procter & Gamble Company
18841637 ENDOSOMAL CLEAVABLE HYDROPHILIC-MASKED CATIONIC CHARGE DELIVERY VEHICLES Non-Final OA The Regents of the University of California
18688943 AN ORAL CARE COMPOSITION COMPRISING A GLYCOLIPID AND A MILD SURFACTANT Final Rejection BASF SE
17756872 DIETARY BUTYRATE AND ITS USES Final Rejection SOCIETE DES PRODUITS NESTLE S.A.
18580076 COMPOSITIONS WITH MICROENCAPSULATED ACETAMIDE AND METAL-CHELATED MESOTRIONE Final Rejection MONSANTO TECHNOLOGY LLC
18859858 ANIMAL FOOD COMPOSITION COMPRISING A SOURCE OF GLYCYRRHIZIN Non-Final OA MARS, INCORPORATED
18278903 MICRONEEDLES AND METHODS FOR TREATING THE SKIN Non-Final OA MASSACHUSETTS INSTITUTE OF TECHNOLOGY
18580498 Method For Spot-Treatment Application Against Weeds Non-Final OA BAYER AKTIENGESELLSCHAFT
18688180 COMPOSITIONS AND METHODS FOR TREATING BONE INJURIES Final Rejection BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
17795099 SUSTAINED-RELEASE MATRICES FOR ADVENTITIAL OR PERIADVENTITIAL NEURAL ABLATION AND USES THEREOF Final Rejection W. L. Gore & Associates, Inc.
18838780 Fumaric Acid Esters, Inhalation Administration Methods, Pharmaceutical Uses and Compositions Non-Final OA Arizona Board of Regents on behalf of the University of Arizona
18073969 MULTILEVEL ANTIMICROBIAL POLYMERIC COLLOIDS AND DEVICE SCREENS CONTAINING SAME Non-Final OA THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY
18490618 HAIR TREATMENT COMPOSITION WITH CATIONIC SURFACTANT, FATTY ALCOHOLS, AND LOW POLAR OIL Non-Final OA L'OREAL
18552540 COMPOSITION FOR CLEANSING AND/OR REMOVING MAKEUPS FROM KERATIN MATERIALS Non-Final OA L'OREAL
18232587 COMPOSITIONS AND METHODS FOR HAIR Non-Final OA L'OREAL
18231735 COMPOSITIONS AND METHODS FOR TREATING KERATIN FIBERS Final Rejection L'Oreal
18265540 COMPOSITION FOR CLEANSING KERATIN MATERIALS Non-Final OA L'OREAL
18115247 COMPOSITIONS AND METHODS FOR CURLY HAIR Non-Final OA L'Oreal
18559842 POWDERY CLEANSING COMPOSITION Non-Final OA BEIERSDORF AG
18001738 FRAGRANCE-STABLE COSMETIC PREPARATION Final Rejection BEIERSDORF AG
17595855 Surface Modified Gas Vesicles, Preparation and Applications thereof Non-Final OA THE HONG KONG POLYTECHNIC UNIVERSITY
18566247 PLACENTA-MIMIC COSMETIC COMPOSITION Non-Final OA LG HOUSEHOLD & HEALTH CARE LTD.
17639699 Cosmetic Composition Comprising Solid Phase Polymer Components Having Improved Solubility Final Rejection LG Household & Health Care Ltd.
18686139 TRANSDERMAL THERAPEUTIC SYSTEM FOR THE TRANSDERMAL ADMINISTRATION OF GUANFACINE COMPRISING GUANFACINE AND A MONO-CARBOXYLIC ACID Non-Final OA LTS LOHMANN THERAPIE-SYSTEME AG
18538047 COMPOSITION CONTAINING RECOMBINANT COLLAGEN WITH REPAIRING AND SOOTHING EFFECTS, EYE CREAM CONTAINING THE COMPOSITION AND PREPARATION METHOD THEREOR Final Rejection MAYINGLONG MASSIVE HEALTH CO., LTD
18246405 HYDROXYAPATITE COMPOSITION FOR TREATMENT AND/OR PREVENTION OF A VIRUS INFECTION Final Rejection DR. KURT WOLFF GMBH & CO. KG
18233659 ORAL ACTIVE AGENT DELIVERY SYSTEM FOR ANIMALS AND METHOD Final Rejection BIRD DOG BIOVENTURES, LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month